Pharmacokinetic scaling and pharmacokinetics/pharmacody-namics for rational prediction of antibacterial dosage regimens in animals to mitigate antimicrobial resistance
Microbes & Immunity · 27.07.2026 · 026210055
DOI: 10.36922/mi026210055 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbes & Immunity, online erschienen am 27.07.2026. Verfasst von Tridib Chaira und 3 weiteren Autor:innen.
Abstract (Originalsprache)
The rapid emergence of antimicrobial resistance (AMR) has become a significant challenge in both human and veterinary medicine, largely driven by the misuse and overuse of antibiotics, including inappropriate cross-species dosage extrapolation. Empirical antimicrobial dosing can result in subtherapeutic exposure, disruption of the microbial ecosystem, and increased selective pressure, thereby accelerating the emergence and dissemination of resistant bacteria. Maintaining microecological homeostasis, particularly the stability of the commensal microbiota, is increasingly recognized as essential for limiting the development of resistance and preserving host health. Although interspecies scaling, Monte Carlo simulations, population pharmacokinetics (PK), and physiologically based PK models have been used to predict dosage regimens, their complexity and extensive data requirements restrict routine application in veterinary practice. In this context, PK/pharmacodynamic (PD) modeling provides a practical and scientifically robust framework for rational antimicrobial therapy. By integrating drug concentration–time profiles with antimicrobial effects, PK/PD-guided approaches enable species-specific dose optimization that improves therapeutic efficacy, minimizes ecological disruption, and reduces AMR selection pressure. This review highlights the application of modern PK/PD strategies in veterinary medicine as an essential tool for sustainable antimicrobial stewardship, AMR mitigation, and preservation of microbial ecosystem stability.
Zitieren
APA
Chaira, T., Kumari, R., Chauhan, S., & Barman, T. K. (2026). Pharmacokinetic scaling and pharmacokinetics/pharmacody-namics for rational prediction of antibacterial dosage regimens in animals to mitigate antimicrobial resistance. Microbes & Immunity, 0(0), 026210055. https://doi.org/10.36922/mi026210055
Vancouver
Chaira T, Kumari R, Chauhan S, Barman TK. Pharmacokinetic scaling and pharmacokinetics/pharmacody-namics for rational prediction of antibacterial dosage regimens in animals to mitigate antimicrobial resistance. Microbes & Immunity. 2026;0(0):026210055. doi:10.36922/mi026210055
BibTeX
@article{Chaira2026,
author = {Chaira, Tridib and Kumari, Rashmi and Chauhan, Shailendra and Barman, Tarani Kanta},
title = {Pharmacokinetic scaling and pharmacokinetics/pharmacody-namics for rational prediction of antibacterial dosage regimens in animals to mitigate antimicrobial resistance},
journal = {Microbes & Immunity},
year = {2026},
volume = {0},
number = {0},
pages = {026210055},
doi = {10.36922/mi026210055}
}
EUVIMED